EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Age and Late Recurrence in Young Patients With ER–Positive, ERBB2 -Negative Breast Cancer

Dong Seung Shin, Janghee Lee, Eunhye Kang, Dasom Noh, Jong-Ho Cheun, Jun-Hee Lee, Yeongyeong Son, Soong June Bae, Seok Won Kim, Jeong Eon Lee, Jonghan Yu, Byung-Joo Chae und 4 weitere

JAMA Network Open · 2024

DOI: 10.1001/jamanetworkopen.2024.42663 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JAMA Network Open, 2024. Verfasst von Dong Seung Shin und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases, Neoplasm Recurrence, Local, Receptors, Estrogen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Young patients with breast cancer with estrogen receptor (ER)–positive, ERBB2 -negative tumors have a poor prognosis. Understanding factors influencing late recurrence is crucial for improving management and outcomes.

Objective

To determine whether age is an independent factor associated with late distant recurrence (DR) in young patients with ER-positive, ERBB2 -negative cancers without distant metastasis within 5 years from surgery. Design, Setting, and Participants This multicenter retrospective cohort study analyzed clinical records of patients with breast cancer who underwent surgery from January 2000 to December 2011 with at least 5 years of follow-up. The study was conducted at Samsung Medical Center, Gangnam Severance Hospital, and Seoul National University Hospital, including patients aged 45 years or younger with ER-positive, ERBB2 -negative tumors, no DR within 5 years after surgery, no neoadjuvant chemotherapy, and at least 2 years of endocrine therapy. The data analysis period was from January 4, 2023, to March 21, 2024. Exposure Age, grouped as 21 to 35 years, 36 to 40 years, and 41 to 45 years. Main Outcomes and Measures The primary outcome was the incidence of late DR at 5 to 10 years after surgery. Survival outcomes, including late distant metastasis–free survival (DMFS), were evaluated in different age groups.

Results

Among 2772 patients included, 370 (13.3%) were aged 21 to 35 years, 885 (31.9%) were aged 36 to 40 years, and 1517 (54.7%) were aged 41 to 45 years. The median (range) follow-up was 10.8 (5.0-21.4) years. The youngest group had a poorer histologic grade (eg, histologic grade 3: 107 patients aged 21-35 years [28.9%]; 149 patients aged 36-40 years [16.8%]; 273 patients aged 41-45 years [18.0%]) and more frequent chemotherapy (307 patients aged 21-35 years [83.0%]; 697 patients aged 36-40 years [78.8%]; 1111 patients aged 41-45 years [73.2%]). The youngest patients had significantly worse rates of locoregional recurrence–free survival (patients aged 21-35 years, 90.1% [95% CI, 86.8%-93.3%]; patients aged 36-40 years, 94.6% [95% CI, 93.0%-96.2%]; patients aged 41-45 years, 97.7% [95% CI, 96.9%-98.5%]), disease-free survival (patients aged 21-35 years, 79.3% [95% CI, 75.0%-83.9%]; patients aged 36-40 years, 88.7% [95% CI, 86.5%-91.0%]; patients aged 41-45 years, 94.4% [95% CI, 93.2%-95.7%]), and late DMFS (patients aged 21-35 years, 89.3% [95% CI, 86.0%-92.9%]; patients aged 36-40 years: 94.2% [95% CI, 92.5%-95.9%]; patients aged 41-45 years: 97.2% [95% CI, 96.3%-98.1%]) but not overall survival (patients aged 21-35 years, 96.9% [95% CI, 95.0%-98.9%]; patients aged 36-40 years, 98.2% [95% CI, 97.2%-99.2%]; patients aged 41-45 years, 98.9% [95% CI, 98.3%-99.5%]). Multivariable analysis showed lower hazard for late DR in the older groups compared with the youngest group (age 36-40 years: hazard ratio, 0.53; 95% CI, 0.34-0.82; P = .001; age 41-45 years: hazard ratio, 0.30; 95% CI, 0.20-0.47; P < .001). Conclusions and Relevance In this retrospective cohort study, age was an independent factor associated with late DR in young patients with ER-positive, ERBB2 -negative breast cancer. Younger age was associated with worse locoregional recurrence–free survival, disease-free survival, and late DMFS, highlighting the importance of long-term monitoring and potential for personalized treatment approaches based on age, particularly for younger patients with ER-positive, ERBB2 -negative breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsErb-b2 Receptor Tyrosine KinasesNeoplasm Recurrence, LocalReceptors, EstrogenHumansFemaleAdultRetrospective StudiesMiddle AgedAge FactorsYoung AdultPrognosisRepublic of Korea

Substanzen

Erb-b2 Receptor Tyrosine KinasesReceptors, EstrogenERBB2 protein, human

Autor:innen und Institutionen

  • Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University of Medicine, Seoul, Republic of Korea.
  • Department of Surgery, Dongtan Sacred Heart Hospital, Hallym University, Dongtan, Republic of Korea.
  • Department of Medicine, Yonsei University Graduate School, Seoul, Republic of Korea.
  • Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Cancer Research Institute, Seoul National University, Seoul, Republic of Korea.
  • Department of Information Convergence Engineering, College of Information and Biomedical Engineering, Pusan National University, Busan, Republic of Korea.

Zitieren

APA

Shin, D. S., Lee, J., Kang, E., Noh, D., Cheun, J. H., Lee, J. H., Son, Y., Bae, S. J., Kim, S. W., Lee, J. E., Yu, J., Chae, B. J., Kwon, S., Lee, H. B., Ahn, S. G., & Ryu, J. M. (2024). Age and Late Recurrence in Young Patients With ER–Positive, ERBB2 -Negative Breast Cancer. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2024.42663

Vancouver

Shin DS, Lee J, Kang E, Noh D, Cheun JH, Lee JH, et al. Age and Late Recurrence in Young Patients With ER–Positive, ERBB2 -Negative Breast Cancer. JAMA Network Open. 2024. doi:10.1001/jamanetworkopen.2024.42663

BibTeX
@article{Shin2024,
  author = {Shin, Dong Seung and Lee, Janghee and Kang, Eunhye and Noh, Dasom and Cheun, Jong-Ho and Lee, Jun-Hee and Son, Yeongyeong and Bae, Soong June and Kim, Seok Won and Lee, Jeong Eon and Yu, Jonghan and Chae, Byung-Joo and Kwon, Sunyoung and Lee, Han-Byoel and Ahn, Sung Gwe and Ryu, Jai Min},
  title = {Age and Late Recurrence in Young Patients With ER–Positive, ERBB2 -Negative Breast Cancer},
  journal = {JAMA Network Open},
  year = {2024},
  doi = {10.1001/jamanetworkopen.2024.42663}
}
Kostenlos starten →